Needham & Company Resumes Plexus (PLXS) at Buy

April 23, 2019 6:51 AM EDT
Get Alerts PLXS Hot Sheet
Price: $92.44 +1.15%

Rating Summary:
    5 Buy, 5 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 9 | Down: 10 | New: 35
Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Needham & Company analyst James Ricchiuti initiates coverage on Plexus (NASDAQ: PLXS) with a Buy rating and a price target of $72.00.

The analyst commented, "We are resuming coverage of PLXS with a Buy rating and $72 target price. PLXS last week reported weaker-than-expected FQ2 EPS despite beating slightly on the top line. And after 5 consecutive quarters of double-digit y/o/y rev growth, mgmt also guided to 5-10% rev growth for FQ3 and disappointing EPS growth of 2.5% at the midpoint of guidance. PLXS shares not surprisingly sold off on the print. We are taking a more constructive view of business conditions, owing to ongoing momentum in manufacturing wins and the strong outlook for growth over the balance of F19 in Health Care/Life Sciences, Aerospace and Defense and Industrial. Excluding its semi-cap and communications business, PLXS’s revs could grow at nearly 20% in F19. We believe the outlook for margins should brighten in FQ4 on higher volumes, improved utilization and cost-containment."

For an analyst ratings summary and ratings history on Plexus click here. For more ratings news on Plexus click here.

Shares of Plexus closed at $60.42 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, New Coverage

Related Entities

Needham & Company